Your browser doesn't support javascript.
loading
Author Correction: Genomic characterization of metastatic breast cancers.
Bertucci, François; Ng, Charlotte K Y; Patsouris, Anne; Droin, Nathalie; Piscuoglio, Salvatore; Carbuccia, Nadine; Soria, Jean Charles; Dien, Alicia Tran; Adnani, Yahia; Kamal, Maud; Garnier, Séverine; Meurice, Guillaume; Jimenez, Marta; Dogan, Semih; Verret, Benjamin; Chaffanet, Max; Bachelot, Thomas; Campone, Mario; Lefeuvre, Claudia; Bonnefoi, Herve; Dalenc, Florence; Jacquet, Alexandra; De Filippo, Maria R; Babbar, Naveen; Birnbaum, Daniel; Filleron, Thomas; Le Tourneau, Christophe; André, Fabrice.
Afiliação
  • Bertucci F; CRCM, Predictive Oncology team, Inserm, Aix-Marseille Univ, CNRS, Institut Paoli-Calmettes, Marseille, France. fandre@igr.fr.
  • Ng CKY; Institute of Pathology, University Hospital Basel, Basel, Switzerland.
  • Patsouris A; Clarunis, Department of Biomedicine, University of Basel, Basel, Switzerland.
  • Droin N; Department for BioMedical Research, University of Bern, Bern, Switzerland.
  • Piscuoglio S; Inserm, U1232, Nantes, France.
  • Carbuccia N; Institut de Cancérologie de l'Ouest - René Gauducheau, Saint Herblain, France.
  • Soria JC; Genomic Core Facility UMS AMMICA Gustave Roussy Cancer Campus, Villejuif, France.
  • Dien AT; INSERM, US23, Villejuif, France.
  • Adnani Y; CNRS, UMS3665, Villejuif, France.
  • Kamal M; Institute of Pathology, University Hospital Basel, Basel, Switzerland.
  • Garnier S; Clarunis, Department of Biomedicine, University of Basel, Basel, Switzerland.
  • Meurice G; CRCM, Predictive Oncology team, Inserm, Aix-Marseille Univ, CNRS, Institut Paoli-Calmettes, Marseille, France.
  • Jimenez M; Université Paris Sud, Orsay, France.
  • Dogan S; Drug Development Department (DITEP), Gustave Roussy Cancer Campus, Villejuif, France.
  • Verret B; Bioinformatics Core Facility, Gustave Roussy Cancer Campus, Villejuif, France.
  • Chaffanet M; Bioinformatics Core Facility, Gustave Roussy Cancer Campus, Villejuif, France.
  • Bachelot T; Department of Translational Research, Institut Curie, Saint-Cloud, France.
  • Campone M; CRCM, Predictive Oncology team, Inserm, Aix-Marseille Univ, CNRS, Institut Paoli-Calmettes, Marseille, France.
  • Lefeuvre C; Bioinformatics Core Facility, Gustave Roussy Cancer Campus, Villejuif, France.
  • Bonnefoi H; Unicancer, Paris, France.
  • Dalenc F; Inserm, Gustave Roussy Cancer Campus, UMR981, Villejuif, France.
  • Jacquet A; Inserm, Gustave Roussy Cancer Campus, UMR981, Villejuif, France.
  • De Filippo MR; CRCM, Predictive Oncology team, Inserm, Aix-Marseille Univ, CNRS, Institut Paoli-Calmettes, Marseille, France.
  • Babbar N; Centre Léon Bérard, Lyon, France.
  • Birnbaum D; Inserm, U1232, Nantes, France.
  • Filleron T; Institut de Cancérologie de l'Ouest - René Gauducheau, Saint Herblain, France.
  • Le Tourneau C; Centre Eugène Marquis, Rennes, France.
  • André F; Institut Bergonié, Bordeaux, France.
Nature ; 572(7767): E7, 2019 Aug.
Article em En | MEDLINE | ID: mdl-31308536
An Amendment to this paper has been published and can be accessed via a link at the top of the paper.
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2019 Tipo de documento: Article